These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9719482)

  • 1. Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cells.
    Jain PT; Fornari FA; Randolph JK; Orr MS; Gewirtz DA
    Biochem Pharmacol; 1998 Apr; 55(8):1263-9. PubMed ID: 9719482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell line.
    Gewirtz DA; Randolph JK; Chawla J; Orr MS; Fornari FA
    Cancer Chemother Pharmacol; 1998; 41(5):361-9. PubMed ID: 9523731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cells.
    Bunch RT; Povirk LF; Orr MS; Randolph JK; Fornari FA; Gewirtz DA
    Biochem Pharmacol; 1994 Jan; 47(2):317-29. PubMed ID: 8304976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of bulk and c-myc P2 promoter-specific DNA damage by an anti-topoisomerase II agent salvicine is an early event leading to apoptosis in HL-60 cells.
    Meng L; Ding J
    FEBS Lett; 2001 Jul; 501(1):59-64. PubMed ID: 11457456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential GADD45, p21CIP1/WAF1, MCL-1 and topoisomerase II gene induction and secondary DNA fragmentation after camptothecin-induced DNA damage in two mutant p53 human colon cancer cell lines.
    Goldwasser F; Bae I; Fornace AJ; Pommier Y
    Oncol Res; 1996; 8(7-8):317-23. PubMed ID: 8938795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation between bulk damage to DNA and the antiproliferative activity of teniposide (VM-26) in the MCF-7 breast tumor cell line: evidence for induction of gene-specific damage and alterations in gene expression.
    Gewirtz DA; Orr MS; Fornari FA; Randolph JK; Yalowich JC; Ritke MK; Povirk LF; Bunch RT
    Cancer Res; 1993 Aug; 53(15):3547-54. PubMed ID: 8339261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UCN-01 and camptothecin induce DNA double-strand breaks in p53 mutant tumor cells, but not in normal or p53 negative epithelial cells.
    Jones CB; Clements MK; Redkar A; Daoud SS
    Int J Oncol; 2000 Nov; 17(5):1043-51. PubMed ID: 11029511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase I as a site of action for 10-hydroxycamptothecin in human promyelocytic leukemia cells.
    Ling YH; Andersson BS; Nelson JA
    Cancer Biochem Biophys; 1990 Jan; 11(1):23-30. PubMed ID: 2159843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA damage, c-myc suppression and apoptosis induced by the novel topoisomerase II inhibitor, salvicine, in human breast cancer MCF-7 cells.
    Lu HR; Meng LH; Huang M; Zhu H; Miao ZH; Ding J
    Cancer Chemother Pharmacol; 2005 Mar; 55(3):286-94. PubMed ID: 15592835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay.
    Godard T; Deslandes E; Sichel F; Poul JM; Gauduchon P
    Mutat Res; 2002 Sep; 520(1-2):47-56. PubMed ID: 12297143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the DNA mismatch repair system in the cytotoxicity of the topoisomerase inhibitors camptothecin and etoposide to human colorectal cancer cells.
    Jacob S; Aguado M; Fallik D; Praz F
    Cancer Res; 2001 Sep; 61(17):6555-62. PubMed ID: 11522654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardioprotective and DNA topoisomerase II inhibitory agent dexrazoxane (ICRF-187) antagonizes camptothecin-mediated growth inhibition of Chinese hamster ovary cells by inhibition of DNA synthesis.
    Hasinoff BB; Chee GL; Thampatty P; Allan WP; Yalowich JC
    Anticancer Drugs; 1999 Jan; 10(1):47-54. PubMed ID: 10194547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional consequences of topoisomerase inhibition.
    Collins I; Weber A; Levens D
    Mol Cell Biol; 2001 Dec; 21(24):8437-51. PubMed ID: 11713279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complex response of breast epithelial cell lines to topoisomerase inhibitors.
    Davis PL; Shaiu WL; Scott GL; Iglehart JD; Hsieh TS; Marks JR
    Anticancer Res; 1998; 18(4C):2919-32. PubMed ID: 9713486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of c-myc expression and c-Myc function in response to sustained DNA damage in MCF-7 breast tumor cells.
    Magnet KJ; Orr MS; Cleveland JL; Rodriguez-Galindo C; Yang H; Yang C; Di YM; Jain PT; Gewirtz DA
    Biochem Pharmacol; 2001 Sep; 62(5):593-602. PubMed ID: 11585056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Camptothecin analogues with enhanced antitumor activity at acidic pH.
    Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
    Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of biphasic DNA double strand breaks and activation of multiple repair protein complexes by DNA topoisomerase I drug 7-ethyl-10-hydroxy-camptothecin.
    Wu J; Yin MB; Hapke G; Tóth K; Rustum YM
    Mol Pharmacol; 2002 Apr; 61(4):742-8. PubMed ID: 11901212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of replicon initiation in human cells following stabilization of topoisomerase-DNA cleavable complexes.
    Kaufmann WK; Boyer JC; Estabrooks LL; Wilson SJ
    Mol Cell Biol; 1991 Jul; 11(7):3711-8. PubMed ID: 1646393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity.
    Morris EJ; Geller HM
    J Cell Biol; 1996 Aug; 134(3):757-70. PubMed ID: 8707853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.